Alembic Pharmaceuticals informs about press release

21 Oct 2020 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg. The company has enclosed its press release on 21st October 2020.

The above information is a part of company’s filings submitted to BSE.


Alembic Pharma Share Price

755.20 -7.35 (-0.96%)
27-Jan-2026 09:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1642.30
Dr. Reddys Lab 1247.40
Cipla 1297.20
Zydus Lifesciences 892.10
Lupin 2159.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×